Sturge-Weber Syndrome
10
1
3
6
Key Insights
Highlights
Success Rate
100% trial completion (above average)
Clinical Risk Assessment
Based on trial outcomes
Moderate Risk
Score: 37/100
0.0%
0 terminated out of 10 trials
100.0%
+13.5% vs benchmark
10%
1 trials in Phase 3/4
50%
3 of 6 completed with results
Key Signals
Data Visualizations
Phase Distribution
Trial Status
Trial Success Rate
Benchmark: 86.5%
Based on 6 completed trials
Clinical Trials (10)
Longitudinal Neuroimaging in Sturge-Weber Syndrome
Innovative Approaches to Gauge Progression of Sturge-Weber Syndrome
Safety and Tolerability Study of QLS-101 in Adolescents With Sturge-Weber Syndrome (SWS)-Related Glaucoma Due to Elevated Episcleral Venous Pressure (EVP)
Longitudinal Studies to Identify Biomarkers for Sturge-Weber Syndrome
Use of a Tonometer to Identify Epileptogenic Lesions During Pediatric Epilepsy Surgery
Novel Cognitive Treatment Targets for Epidiolex in Sturge- Weber Syndrome
Cannabidiol Expanded Access Study in Medically Refractory Sturge-Weber Syndrome
A New Approach in Laser Surgery Using the Regenerative Solution in Children Diagnosed With Vascular Pathology
Trial of Sirolimus for Cognitive Impairment in Sturge-Weber Syndrome
Biomarker Development in Sturge-Weber Syndrome